Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes - PubMed (original) (raw)
doi: 10.1038/sj.ejhg.5200698.
A Zimprich, P J Lockhart, M Farrer, A Singleton, B Holtom, S Lincoln, A Hofer, L Hill, B Müller-Myhsok, Z K Wszolek, J Hardy, T Gasser
Affiliations
- PMID: 11571553
- DOI: 10.1038/sj.ejhg.5200698
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes
A B West et al. Eur J Hum Genet. 2001 Sep.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder with clinical features of bradykinesia, rigidity, resting tremor and postural instability resulting from the deficiency of dopamine in the nigrostriatal system. Previously we mapped a susceptibility gene for an autosomal dominant form of PD to a 10.6 cM region of chromosome 2p (PARK3; OMIM 602404). A common haplotype shared by two North American kindreds (Families B and C) genealogically traced to Southern Denmark and Northern Germany suggested a founder effect. Here we report progress in the refinement of the PARK3 locus and sequence analysis of candidate genes within the region. Members of families B and C were genotyped using polymorphic markers, reducing the minimum common haplotype to eight markers spanning a physical distance of 2.5 Mb. Analysis of 14 genes within the region did not reveal any potentially pathogenic mutations segregating with the disease, implying that none of these genes are likely candidates for PARK3.
Similar articles
- The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3.
Lockhart PJ, Holtom B, Lincoln S, Hussey J, Zimprich A, Gasser T, Wszolek ZK, Hardy J, Farrer MJ. Lockhart PJ, et al. Gene. 2002 Feb 20;285(1-2):229-37. doi: 10.1016/s0378-1119(02)00402-x. Gene. 2002. PMID: 12039050 - A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.
Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Sullivan KM, Xu G, Watts R, Growdon J, Lew M, Waters C, Vieregge P, Pramstaller PP, Klein C, Racette BA, Perlmutter JS, Parsian A, Singer C, Montgomery E, Baker K, Gusella JF, Fink SJ, Myers RH, Herbert A; GenePD study. Karamohamed S, et al. Neurology. 2003 Dec 9;61(11):1557-61. doi: 10.1212/01.wnl.0000095966.99430.f4. Neurology. 2003. PMID: 14663042 - Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson's disease from northern Germany.
Klein C, Vieregge P, Hagenah J, Sieberer M, Doyle E, Jacobs H, Gasser T, Breakefield XO, Risch NJ, Ozelius LJ. Klein C, et al. Ann Hum Genet. 1999 Jul;63(Pt 4):285-91. doi: 10.1046/j.1469-1809.1999.6340285.x. Ann Hum Genet. 1999. PMID: 10738540 - A physical and transcript map based upon refinement of the critical interval for PPH1, a gene for familial primary pulmonary hypertension. The International PPH Consortium.
Machado RD, Pauciulo MW, Fretwell N, Veal C, Thomson JR, Vilariño Güell C, Aldred M, Brannon CA, Trembath RC, Nichols WC. Machado RD, et al. Genomics. 2000 Sep 1;68(2):220-8. doi: 10.1006/geno.2000.6291. Genomics. 2000. PMID: 10964520 - Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions.
McKnight I, Hart C, Park IH, Shim JW. McKnight I, et al. Exp Neurol. 2021 Jan;335:113523. doi: 10.1016/j.expneurol.2020.113523. Epub 2020 Nov 4. Exp Neurol. 2021. PMID: 33157092 Free PMC article. Review.
Cited by
- Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
Simón-Sánchez J, Singleton AB. Simón-Sánchez J, et al. Hum Mol Genet. 2008 Jul 1;17(13):1988-93. doi: 10.1093/hmg/ddn096. Epub 2008 Mar 25. Hum Mol Genet. 2008. PMID: 18364387 Free PMC article. - Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease.
Martinez M, Brice A, Vaughan JR, Zimprich A, Breteler MM, Meco G, Filla A, Farrer MJ, Bétard C, Hardy J, De Michele G, Bonifati V, Oostra B, Gasser T, Wood NW, Dürr A; French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. Martinez M, et al. J Med Genet. 2004 Dec;41(12):900-7. doi: 10.1136/jmg.2004.022632. J Med Genet. 2004. PMID: 15591275 Free PMC article. - Transcriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1.
McHugh PC, Wright JA, Brown DR. McHugh PC, et al. PLoS One. 2011 Feb 28;6(2):e17354. doi: 10.1371/journal.pone.0017354. PLoS One. 2011. PMID: 21386983 Free PMC article. - Sepiapterin reductase expression is increased in Parkinson's disease brain tissue.
Tobin JE, Cui J, Wilk JB, Latourelle JC, Laramie JM, McKee AC, Guttman M, Karamohamed S, DeStefano AL, Myers RH. Tobin JE, et al. Brain Res. 2007 Mar 30;1139:42-7. doi: 10.1016/j.brainres.2007.01.001. Epub 2007 Jan 8. Brain Res. 2007. PMID: 17270157 Free PMC article. - The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations.
Sharma M, Mueller JC, Zimprich A, Lichtner P, Hofer A, Leitner P, Maass S, Berg D, Dürr A, Bonifati V, De Michele G, Oostra B, Brice A, Wood NW, Muller-Myhsok B, Gasser T; European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD). Sharma M, et al. J Med Genet. 2006 Jul;43(7):557-62. doi: 10.1136/jmg.2005.039149. Epub 2006 Jan 27. J Med Genet. 2006. PMID: 16443856 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous